
Drawing a comparison between India and China, Dr Mishra said that India has strong protection of hybrid immunity due to exposure either symptomatic or asymptomatic and China has not developed that situation.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Dp2n53g
via
IFTTT
0 comments:
Post a Comment